In the ever-evolving field of diabetes management, glucagon-like peptide-1 receptor agonists have emerged as a transformative therapeutic class. Among these, retaglutide, retatrutide, and trizepatide represent advanced https://jakubodzr662785.blogzet.com/glp-1-receptor-agonists-retaglutide-retatrutide-and-trizepatide-53873511